- JP-listed companies
- BrightPath Biotherapeutics Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.JP:4594
Market cap
¥3.7B
P/E ratio
| Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
| Cash and deposits | - | 824 | 2,555 | 4,951 | 6,529 | 4,901 | 3,018 | 3,265 | 2,305 | 1,531 | 1,057 |
| Accounts receivable - trade | - | 80 | 107 | 55 | 77 | 1 | 1 | 0 | 17 | 0 | 0 |
| Other | - | 12 | 10 | 55 | 72 | 260 | 309 | 385 | 374 | 120 | 124 |
| Current assets | - | 1,156 | 2,791 | 5,239 | 6,900 | 5,162 | 3,328 | 3,651 | 2,696 | 1,651 | 1,181 |
| Buildings, net | - | 15 | 12 | 39 | 59 | - | - | - | - | - | - |
| Machinery and equipment, net | - | 1 | 1 | 0 | 0 | - | - | - | - | - | - |
| Tools, furniture and fixtures, net | - | 30 | 35 | 77 | 208 | 91 | 97 | 48 | 25 | - | - |
| Property, plant and equipment | - | 45 | 49 | 116 | 266 | 91 | 97 | 48 | 25 | - | - |
| Software | - | 2 | 2 | - | - | - | - | - | - | - | - |
| Intangible assets | - | 2 | 11 | 14 | 14 | - | - | - | - | - | - |
| Long-term prepaid expenses | - | - | 2 | - | - | - | - | - | - | - | - |
| Other | - | - | - | 39 | 56 | 52 | 49 | 50 | 50 | 50 | 49 |
| Investments and other assets | - | 24 | 26 | 39 | 56 | 52 | 49 | 50 | 50 | 50 | 49 |
| Non-current assets | - | 71 | 86 | 169 | 336 | 143 | 146 | 98 | 75 | 50 | 49 |
| Assets | - | 1,227 | 2,877 | 5,408 | 7,236 | 5,304 | 3,475 | 3,749 | 2,771 | 1,701 | 1,230 |
| Accounts payable - trade | - | 58 | 66 | 23 | 9 | 28 | 1 | 0 | 2 | 0 | 0 |
| Current portion of bonds payable | - | - | - | - | - | - | - | - | 88 | - | 113 |
| Accounts payable - other | - | 45 | 30 | 89 | 164 | 74 | 128 | 112 | 46 | 57 | 53 |
| Accrued expenses | - | 2 | 3 | - | - | 6 | 2 | 7 | 5 | 4 | 6 |
| Income taxes payable | - | 5 | 10 | 25 | 35 | 32 | 34 | 32 | 39 | 10 | 13 |
| Deposits received | - | 2 | 3 | - | - | 6 | 7 | 5 | 5 | 5 | 7 |
| Current liabilities | - | 179 | 129 | 161 | 229 | 149 | 173 | 156 | 185 | 77 | 191 |
| Deferred tax liabilities | - | - | - | - | - | 5 | - | - | - | - | - |
| Provision for retirement benefits | - | 15 | 19 | - | - | 33 | 44 | 33 | 33 | 35 | 38 |
| Asset retirement obligations | - | 7 | 7 | 17 | 20 | 22 | 22 | 22 | 22 | 23 | 23 |
| Non-current liabilities | - | 24 | 28 | 46 | 56 | 60 | 67 | 55 | 55 | 57 | 60 |
| Liabilities | - | 203 | 157 | 207 | 285 | 208 | 239 | 212 | 240 | 134 | 251 |
| Share capital | - | 643 | 1,988 | 3,774 | 5,420 | 5,428 | 5,433 | 6,460 | 6,700 | 362 | 651 |
| Legal capital surplus | - | 626 | 1,972 | - | - | 5,411 | 5,417 | 6,443 | 6,684 | 262 | 551 |
| Other capital surplus | - | - | - | - | - | - | - | - | - | 2,409 | 2,409 |
| Capital surplus | - | 626 | 1,972 | 3,758 | 5,404 | 5,411 | 5,417 | 6,443 | 6,684 | 2,671 | 2,959 |
| Retained earnings brought forward | - | -245 | -1,239 | - | - | -5,814 | -7,672 | -9,392 | -10,876 | -1,486 | -2,654 |
| Retained earnings | - | -245 | -1,239 | -2,353 | -3,930 | -5,814 | -7,672 | -9,392 | -10,876 | -1,486 | -2,654 |
| Treasury shares | - | - | - | - | - | - | - | - | - | - | - |
| Shareholders' equity | - | 1,024 | 2,721 | 5,180 | 6,894 | 5,025 | 3,178 | 3,511 | 2,509 | 1,547 | 956 |
| Share acquisition rights | - | - | - | 20 | 57 | 71 | 57 | 26 | 23 | 20 | 23 |
| Net assets | 189 | 1,024 | 2,721 | 5,201 | 6,951 | 5,096 | 3,235 | 3,538 | 2,531 | 1,568 | 979 |
| Liabilities and net assets | - | 1,227 | 2,877 | 5,408 | 7,236 | 5,304 | 3,475 | 3,749 | 2,771 | 1,701 | 1,230 |